[1]
“Pattern of adverse drug reactions of cisplatin based drug regimen in a tertiary care cancer institute”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 5, no. 1, pp. 1–7, May 2021, doi: 10.61096/ijrpp.v5.iss1.2016.1-7.